CSL Limited (OTCMKTS:CSLLY) Short Interest Up 4,100.0% in March

CSL Limited (OTCMKTS:CSLLY) saw a large growth in short interest in March. As of March 31st, there was short interest totalling 12,600 shares, a growth of 4,100.0% from the March 15th total of 300 shares. Based on an average daily volume of 201,200 shares, the short-interest ratio is currently 0.1 days. Currently, 0.0% of the shares of the stock are short sold.

Analyst Upgrades and Downgrades

Separately, The Goldman Sachs Group upgraded shares of CSL to a “strong-buy” rating in a research report on Thursday, January 16th.

CSL Stock Performance

OTCMKTS:CSLLY opened at $77.94 on Wednesday. CSL has a one year low of $70.22 and a one year high of $109.00. The company has a quick ratio of 0.97, a current ratio of 2.18 and a debt-to-equity ratio of 0.58. The stock has a 50 day moving average price of $79.72 and a 200 day moving average price of $87.29.

About CSL

CSL Limited researches, develops, manufactures, markets, and distributes biopharmaceutical and vaccines in Australia, the United States, Germany, the United Kingdom, Switzerland, China, Hong Kong, and internationally. The company operates through CSL Behring, CSL Seqirus, and CSL Vifor segments. The CSL Behring segment offers plasma products, gene therapies, and recombinants.